Nanopharm-logo-with-signature-Pantone (1)
Close this search box.

18 May 2004

Cohesive-Adhesive Balances in DPIs


This research paper explores the intricate balances of cohesive and adhesive forces within dry powder inhaler dDPI) formulations. It elucidates the novel use of Atomic Force Microscopy (AFM) to directly quantify these balances, providing valuable insights into the development of effective inhaler formulations.

The paper discusses the role of engineered crystal substrates in providing suitable surfaces for quantitative analysis of force balance in model dry powder formulations. It further explores interaction force measurements between various substances, including budesonide, lactose, and salbutamol sulfate colloid probes, and engineered substrate surfaces.

The concept of Cohesive-Adhesive Balance (CAB) and its dependency between different interaction combinations is also explored. The challenges and limitations in quantifying force measurements are highlighted, with a solution proposed by comparing the ratios of adhesive and cohesive balances rather than the separation forces.

Related Posts


Nanopharm Announces Exclusive Collaboration With Fluidda To Accelerate Regulatory Pathway For OINDP Using SmartTrack

Crystal Lake, Illinois, September 22, 2022 – Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products (OINDPs), today announced an exclusive collaboration with Fluidda, a leader in the field of Functional Respiratory Imaging. The companies will leverage their respective proprietary technology platforms to help accelerate U.S. Food & Drug Administration (FDA) approvals for orally inhaled generic products (OIDPs) via the alternative bioequivalence pathway. Nanopharm was acquired by Aptar (NYSE: ATR) in 2019, as part of the company’s strategy to expand its services offerings and partner with pharmaceutical companies earlier in the drug development process.

Read More »